We aimed to evaluate the long-term outcomes of computed tomography-guided percutaneous cryoablation (PCA) for biopsy-confirmed renal cell carcinoma (RCC).
This was a single-center, retrospective study investigating all patients treated with PCA between January 2010 and February 2019 for RCC tumors.